Literature DB >> 7891363

Nonsecretory multiple myeloma in a dog: immunohistologic and ultrastructural observations.

S L Marks1, P F Moore, D W Taylor, R J Munn.   

Abstract

A 12-year-old, female spayed Chihuahua was diagnosed with nonsecretory multiple myeloma on the basis of multiple osteolytic lesions, histological evidence of plasma cell infiltrate on a bone biopsy, and absence of a monoclonal protein on serum and urine electrophoresis. A 6-week course of prednisone therapy resulted in no clinical improvement and the dog was euthanized 2 weeks after presentation because of progressive neurological impairment. Bone marrow specimens were processed and stained for ultrastructural and immunohistologic evaluation. Staining with antisera to immunoglobulin (Ig) G, IgM, and IgA was negative. Tumor cells in both the pelvic and rib masses displayed prominent reactivity with an antibody specific for a canine beta 1 integrin similar to VLA-4; however, the tumor cells failed to stain with antibodies known to react predominantly with antigens on B-lymphocytes (major histocompatibility complex class II, CD45RA, and CD21) or T-lymphocytes (Thy-1). The tumor cells also failed to stain with an antibody specific for the beta-subunit (CD18) of the leukocyte integrins (D11/CD18). Ultrastructural studies performed on bone marrow specimens revealed a pleomorphic population of plasma cells with moderate amounts of rough endoplasmic reticulum, erythrophagocytosis, and lack of crystalline inclusions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7891363     DOI: 10.1111/j.1939-1676.1995.tb03272.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  2 in total

Review 1.  A review of immunologic diseases of the dog.

Authors:  N C Pedersen
Journal:  Vet Immunol Immunopathol       Date:  1999-08-02       Impact factor: 2.046

2.  Erythrophagocytic multiple myeloma in a dog.

Authors:  Pierpaolo Romanelli; Camilla Recordati; Paola Rigamonti; Walter Bertazzolo
Journal:  J Vet Diagn Invest       Date:  2022-05-21       Impact factor: 1.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.